secwatch.observer — SEC 8-K summary
======================================

Issuer:     ONCOSEC MEDICAL Inc (—)
CIK:        0001444307
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001493152-23-021288
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 2.04, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

OncoSec Medical files Chapter 7 bankruptcy; board and CEO resign; $2M note accelerated
--------------------------------------------------------------------------------

- Company filed voluntary Chapter 7 petition on June 14, 2023, in New Jersey Bankruptcy Court.
- Chapter 7 trustee will be appointed to liquidate assets and administer the bankruptcy estate.
- Subsidiary OncoSec Medical Australia Pty Ltd expects to wind down via creditors' voluntary liquidation.
- Filing triggered default under $2M convertible note with Grand Decade Developments, accelerating principal and interest.
- Entire 7-member board resigned and CEO Robert Arch resigned immediately after filing; no officers remain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444307/000149315223021288/0001493152-23-021288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444307/000149315223021288/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-021288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer